Microcarrier

Last updated

A microcarrier is a support matrix that allows for the growth of adherent cells in bioreactors. Instead of on a flat surface, cells are cultured on the surface of spherical microcarriers so that each particle carries several hundred cells, and therefore expansion capacity can be multiplied several times over. [1] It provides a straightforward way to scale up culture systems for industrial production of cell or protein-based therapies, or for research purposes. [2] [3]

Contents

These solid or porous spherical matrices range anywhere between 100-300 um in diameter to allow sufficient surface area while retaining enough cell adhesion and support, and their density is minimally above that of water (1 g/ml) so that they remain in suspension in a stirred tank. [1] [4] They can be composed of either synthetic materials such as acrylamide or natural materials such as gelatin. [2] [3]

The advantages of microcarrier technology in the biotech industry include (a) ease of scale-up, (b) ability to precisely control cell growth conditions in sophisticated, computer-controlled bioreactors, (c) an overall reduction in the floor space and incubator volume required for a given-sized manufacturing operation, (d) a drastic reduction in technician labor, and (e) a more natural environment for cell culture that promotes differentiation. [5]

Human iPSCs cultured on microcarriers in a spinner flask.

Microcarrier composition

Synthetic and natural microcarriers

There are several types of microcarriers that can be used, the selection of which is crucial for optimal performance for the application. Early in microcarrier development history, synthetic materials were overwhelmingly used, as they allowed for easy control of mechanical properties and reproducible results for the evaluation of their performance. [3] These materials include DEAE-dextran, glass, polystyrene plastic, and acrylamide. [3] In 1967, microcarrier development began when van Wezel found that the material could support the growth of anchorage-dependent cells, and he used diethylaminoethyl–Sephadex microcarriers. [3] However, synthetic polymers prevent sufficient cell interactions with their environment and stunts their growth. [4] Cells may not differentiate properly without feedback from their environment, and attachment levels would be low. [3] Therefore, the second generation of microcarrier development involves use of natural polymers such as gelatin, collagen, chitin and its derivatives, and cellulose. [2] Not only are these materials easily obtained, but the natural materials provide attachment sites for cells and a similar microenvironment that provides the cell signaling pathways necessary for their proper differentiation. [3] Furthermore, as these are biocompatible, the resulting suspension can be used for delivery of cell therapies in vivo. [1]

Solid and porous microcarriers

Although liquid microcarriers have been developed, a large majority of commercially available microcarriers are solid particles, synthesized through suspension polymerization. [3] However, cells grown on solid microcarriers risk damage from external forces and collisions with other particles and the tank. [4] Therefore, extra precaution must be taken on determining the stir speed and mechanism, so that the resulting fluid dynamic forces are not strong enough to adversely affect culture. [4] [3] The development of porous microcarriers greatly expanded the capabilities of this technology as it further increased the number of cells that the material can hold, but more importantly, it shielded those within the particle from external forces. [3] These include drag and frictional forces of the suspension fluid, pressure gradients, and shear stresses. [1] The 1980s were marked with a wave of microcarrier development with the breakthrough of porous particles. [4]

Surface modifications

Microcarriers of the same material can differ in their porosity, specific gravity, optical properties, presence of animal components, and surface chemistries. [4] Surface chemistries can include extracellular matrix proteins, functional groups, recombinant proteins, peptides, and positively or negatively charged molecules, added through conjugation, co-polymerization, plasma treatment or grafting. [3] These may serve to provide higher attachment levels of the cells to the particles, provide a controlled release for isolation, or make the particles more thermally and physically resistant, among other reasons. [3]

Several types of microcarriers are available commercially including alginate-based (GEM, Global Cell Solutions), dextran-based (Cytodex, GE Healthcare), collagen-based (Cultispher, Percell), and polystyrene-based (SoloHill Engineering) microcarriers. [5]  

Table 1. Commercially available microcarriers and their properties. [3]
NameSize (μm)Density (g/mL)Material
Cytodex-160–871.03Dextran matrix with positively charged diethylaminoethyl groups throughout the matrix
Cytodex-260–871.04Dextran matrix with N,N,N-trimethyl-2-hydroxyaminopropyl groups
Cytodex-360–871.04Dextran beads coated with denatured porcine-skin collagen bound to surface
Cytopore 1200–2801.03Cellulose
CultiSpher G130–3801.04Cross-linked porcine gelatin
CultiSpher S130–3801.04Cross-linked porcine gelatin
Hillex150–2101.1Dextran matrix with treated surface
Glass coated90–1501.05Glass

Advantages over traditional cell culture

Expansion capacity

A prominent advantage in using microcarrier suspensions for the culture of cells over traditional two-dimensional plates is its capacity to hold more cells in smaller volumes. [1] [6] A hallmark of regular cell culture lab protocol is continual passaging as the cells reach confluence on plates fairly quickly, a bottleneck in biologics production. [1] Multilayer vessels, stacked plates, hollow fibers, and packed bed reactors were other technologies developed to combat this capacity limit in plate cell culture [1] . [2] Although they were an improvement, cell numbers produced through these methods still did not reach the threshold for clinical applications. [2] Microcarrier cell culture, however, was the breakthrough required for cell culture to reach industrial and clinical significance. [2] Studies have shown that microcarrier suspensions, compared to multi-layer vessel culture, improve cell yield by 80-fold at only ten percent of Good Manufacturing Practice space, and only sixty percent of the original cost. [4] Without the need for continual passaging, there is less risk of bacterial contamination and labor costs are minimized as well. [2]

Homogeneity

Two-dimensional culture also suffers from poor diffusivity of nutrients and gases, requiring added media and supplements to be manually evenly distributed, and may result in irreproducible data. [1] [2] Microcarrier cell suspensions in stirred tank bioreactors allows for an even distribution through homogenous stirring. [1] Parameters such as pH, oxygen pressure, and media supplement concentrations can be continually monitored within a bioreactor as opposed to manually testing small samples from plates. [2] However, high stir speeds can cause damaging collisions between particles and against the reactor, and too low of a speed can inhibit cell growth by causing an accumulation of particles in a ‘dead zone’ and preventing an even distribution of essential nutrients. [1] [4] Therefore, a minimum and maximum velocity gradients must be calculated so as to keep the suspension homogeneous but also sheltered from unnecessary forces. [2] [6] Often the most efficient mechanism for this is an axial stirrer within the bioreactor, which allows for efficient mixing at minimal stir speeds. [4] The homogenous nature of well-functioning bioreactors also allows for simple sampling and monitoring procedures, compared to two dimensional culture which often suffers from tedious sampling procedures. [4] [2] [6]

Physiological microenvironment

Furthermore, the three-dimensional and high-density suspension environment promotes natural cell morphology and differentiation through mechanical stimulation. [1] On the other hand, two-dimensional plate culture tends to de-differentiate cells over several passages and therefore total passage number must be limited. [1]

Industrial translation

Microcarrier suspensions are also easily scaled up, through larger concentrations of microparticles in larger stirred tank reactors, while laboratory space used for culture can be still kept to a minimum. [2] However, a scale-up of the microcarrier platform also entails certain challenges in the downstream production process. [4] This includes a reworking of the cell detachment and isolation processes. [4] Larger volumes of suspension liquid must be removed from larger vats of bioreactors, and therefore more equipment must be purchased to handle tens to hundreds of liters of solution instead of the standard milliliter. [4]

Biocompatibility

Microcarriers are being investigated to deliver cells for targeted tissue engineering. [3] Hepatocytes, chondrocytes, fibroblasts and more have been successfully delivered using biocompatible microcarriers to in vivo targets for the repair of damaged tissues. [1] Microcarriers can also be used to deliver small molecules and proteins for the same purpose. [5]

Application

A liquid-based assembly method was developed by P. Chen et al. for assembling cell-seeded microcarriers into diverse structures. Neuron-seeded microcarriers were assembled for formation of 3D neural networks with controlled global shape. This method is potentially useful for tissue engineering and neuroscience. [7]

Related Research Articles

<span class="mw-page-title-main">Tissue engineering</span> Biomedical engineering discipline

Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, materials methods, and suitable biochemical and physicochemical factors to restore, maintain, improve, or replace different types of biological tissues. Tissue engineering often involves the use of cells placed on tissue scaffolds in the formation of new viable tissue for a medical purpose but is not limited to applications involving cells and tissue scaffolds. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance it can be considered as a field of its own.

<span class="mw-page-title-main">Bioreactor</span> System that supports a biologically active environment

A bioreactor refers to any manufactured device or system that supports a biologically active environment. In one case, a bioreactor is a vessel in which a chemical process is carried out which involves organisms or biochemically active substances derived from such organisms. This process can either be aerobic or anaerobic. These bioreactors are commonly cylindrical, ranging in size from litres to cubic metres, and are often made of stainless steel. It may also refer to a device or system designed to grow cells or tissues in the context of cell culture. These devices are being developed for use in tissue engineering or biochemical/bioprocess engineering.

<span class="mw-page-title-main">Cell culture</span> Process by which cells are grown under controlled conditions

Cell culture or tissue culture is the process by which cells are grown under controlled conditions, generally outside of their natural environment. The term "tissue culture" was coined by American pathologist Montrose Thomas Burrows. This technique is also called micropropagation. After the cells of interest have been isolated from living tissue, they can subsequently be maintained under carefully controlled conditions. They need to be kept at body temperature (37 °C) in an incubator. These conditions vary for each cell type, but generally consist of a suitable vessel with a substrate or rich medium that supplies the essential nutrients (amino acids, carbohydrates, vitamins, minerals), growth factors, hormones, and gases (CO2, O2), and regulates the physio-chemical environment (pH buffer, osmotic pressure, temperature). Most cells require a surface or an artificial substrate to form an adherent culture as a monolayer (one single-cell thick), whereas others can be grown free floating in a medium as a suspension culture. This is typically facilitated via use of a liquid, semi-solid, or solid growth medium, such as broth or agar. Tissue culture commonly refers to the culture of animal cells and tissues, with the more specific term plant tissue culture being used for plants. The lifespan of most cells is genetically determined, but some cell-culturing cells have been “transformed” into immortal cells which will reproduce indefinitely if the optimal conditions are provided.

Stromal cells, or mesenchymal stromal cells, are differentiating cells found in abundance within bone marrow but can also be seen all around the body. Stromal cells can become connective tissue cells of any organ, for example in the uterine mucosa (endometrium), prostate, bone marrow, lymph node and the ovary. They are cells that support the function of the parenchymal cells of that organ. The most common stromal cells include fibroblasts and pericytes. The term stromal comes from Latin stromat-, "bed covering", and Ancient Greek στρῶμα, strôma, "bed".

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. As of 2016, the only established therapy using stem cells is hematopoietic stem cell transplantation. This usually takes the form of a bone-marrow transplantation, but the cells can also be derived from umbilical cord blood. Research is underway to develop various sources for stem cells as well as to apply stem-cell treatments for neurodegenerative diseases and conditions such as diabetes and heart disease.

Articular cartilage, most notably that which is found in the knee joint, is generally characterized by very low friction, high wear resistance, and poor regenerative qualities. It is responsible for much of the compressive resistance and load bearing qualities of the knee joint and, without it, walking is painful to impossible. Osteoarthritis is a common condition of cartilage failure that can lead to limited range of motion, bone damage and invariably, pain. Due to a combination of acute stress and chronic fatigue, osteoarthritis directly manifests itself in a wearing away of the articular surface and, in extreme cases, bone can be exposed in the joint. Some additional examples of cartilage failure mechanisms include cellular matrix linkage rupture, chondrocyte protein synthesis inhibition, and chondrocyte apoptosis. There are several different repair options available for cartilage damage or failure.

A nerve guidance conduit is an artificial means of guiding axonal regrowth to facilitate nerve regeneration and is one of several clinical treatments for nerve injuries. When direct suturing of the two stumps of a severed nerve cannot be accomplished without tension, the standard clinical treatment for peripheral nerve injuries is autologous nerve grafting. Due to the limited availability of donor tissue and functional recovery in autologous nerve grafting, neural tissue engineering research has focused on the development of bioartificial nerve guidance conduits as an alternative treatment, especially for large defects. Similar techniques are also being explored for nerve repair in the spinal cord but nerve regeneration in the central nervous system poses a greater challenge because its axons do not regenerate appreciably in their native environment.

<span class="mw-page-title-main">Bio-MEMS</span>

Bio-MEMS is an abbreviation for biomedical microelectromechanical systems. Bio-MEMS have considerable overlap, and is sometimes considered synonymous, with lab-on-a-chip (LOC) and micro total analysis systems (μTAS). Bio-MEMS is typically more focused on mechanical parts and microfabrication technologies made suitable for biological applications. On the other hand, lab-on-a-chip is concerned with miniaturization and integration of laboratory processes and experiments into single chips. In this definition, lab-on-a-chip devices do not strictly have biological applications, although most do or are amenable to be adapted for biological purposes. Similarly, micro total analysis systems may not have biological applications in mind, and are usually dedicated to chemical analysis. A broad definition for bio-MEMS can be used to refer to the science and technology of operating at the microscale for biological and biomedical applications, which may or may not include any electronic or mechanical functions. The interdisciplinary nature of bio-MEMS combines material sciences, clinical sciences, medicine, surgery, electrical engineering, mechanical engineering, optical engineering, chemical engineering, and biomedical engineering. Some of its major applications include genomics, proteomics, molecular diagnostics, point-of-care diagnostics, tissue engineering, single cell analysis and implantable microdevices.

<span class="mw-page-title-main">Plant tissue culture</span> Growing plant cells under known conditions

Plant tissue culture is a collection of techniques used to maintain or grow plant cells, tissues, or organs under sterile conditions on a nutrient culture medium of known composition. It is widely used, to produce clones of a plant in a method known as micropropagation. Different techniques in plant tissue culture may offer certain advantages over traditional methods of propagation, including:

Nano-scaffolding or nanoscaffolding is a medical process used to regrow tissue and bone, including limbs and organs. The nano-scaffold is a three-dimensional structure composed of polymer fibers very small that are scaled from a Nanometer scale. Developed by the American military, the medical technology uses a microscopic apparatus made of fine polymer fibers called a scaffold. Damaged cells grip to the scaffold and begin to rebuild missing bone and tissue through tiny holes in the scaffold. As tissue grows, the scaffold is absorbed into the body and disappears completely.

Human platelet lysate is a substitute supplement for fetal bovine serum (FBS) in experimental and clinical cell culture. It is a turbid, light-yellow liquid that is obtained from human blood platelets after freeze/thaw cycle(s). The freeze/thaw cycle causes the platelets to lyse, releasing a large quantity of growth factors necessary for cell expansion. hPL has the highest concentration of growth factors of any serum suppliments. FBS-free cell culture media, e.g. with platelet lysate or chemically defined/ animal component free, are used for cell therapy or regenerative medicine. They are commercially available in GMP -quality which is generally basis for regulatory approval.

Dermal fibroblasts are cells within the dermis layer of skin which are responsible for generating connective tissue and allowing the skin to recover from injury. Using organelles, dermal fibroblasts generate and maintain the connective tissue which unites separate cell layers. Furthermore, these dermal fibroblasts produce the protein molecules including laminin and fibronectin which comprise the extracellular matrix. By creating the extracellular matrix between the dermis and epidermis, fibroblasts allow the epithelial cells of the epidermis to affix the matrix, thereby allowing the epidermal cells to effectively join together to form the top layer of the skin.

A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments, a 3D cell culture allows cells in vitro to grow in all directions, similar to how they would in vivo. These three-dimensional cultures are usually grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. Approximately 300 spheroids are usually cultured per bioreactor.

A Muse cell is an endogenous non-cancerous pluripotent stem cell. They reside in the connective tissue of nearly every organ including the umbilical cord, bone marrow and peripheral blood. They are collectable from commercially obtainable mesenchymal cells such as human fibroblasts, bone marrow-mesenchymal stem cells and adipose-derived stem cells. Muse cells are able to generate cells representative of all three germ layers from a single cell both spontaneously and under cytokine induction. Expression of pluripotency genes and triploblastic differentiation are self-renewable over generations. Muse cells do not undergo teratoma formation when transplanted into a host environment in vivo. This can be explained in part by their intrinsically low telomerase activity, eradicating the risk of tumorigenesis through unbridled cell proliferation. They were discovered in 2010 by Mari Dezawa and her research group. Clinical trials for acute myocardial infarction, stroke, epidermolysis bullosa, spinal cord injury, amyotrophic lateral sclerosis, acute respiratory distress syndrome (ARDS) related to novel coronavirus (SARS-CoV-2) infection, are conducted by Life Science Institute, Inc., a group company of Mitsubishi Chemical Holdings company. Physician-led clinical trial for neonatal hypoxic-ischemic encephalopathy was also started. The summary results of a randomized double-blind placebo-controlled clinical trial in patients with stroke was announced.

The in vivo bioreactor is a tissue engineering paradigm that uses bioreactor methodology to grow neotissue in vivo that augments or replaces malfunctioning native tissue. Tissue engineering principles are used to construct a confined, artificial bioreactor space in vivo that hosts a tissue scaffold and key biomolecules necessary for neotissue growth. Said space often requires inoculation with pluripotent or specific stem cells to encourage initial growth, and access to a blood source. A blood source allows for recruitment of stem cells from the body alongside nutrient delivery for continual growth. This delivery of cells and nutrients to the bioreactor eventually results in the formation of a neotissue product. 

A Hollow fiber bioreactor is a 3 dimensional cell culturing system based on hollow fibers, which are small, semi-permeable capillary membranes arranged in parallel array with a typical molecular weight cut-off (MWCO) range of 10-30 kDa. These hollow fiber membranes are often bundled and housed within tubular polycarbonate shells to create hollow fiber bioreactor cartridges. Within the cartridges, which are also fitted with inlet and outlet ports, are two compartments: the intracapillary (IC) space within the hollow fibers, and the extracapillary (EC) space surrounding the hollow fibers.

Gelatin Microparticles are polymer microparticles constructed of gelatin. Gelatin, a bipolymer, is produced through the hydrolysis of collagen. Gelatin, along with its more familiar uses, is widely used for the production of microparticles due to its efficiency in forming gels as well as its biodegradability as a particle. Gelatin can be manipulated to form a stable matrix for biologically reactive compounds, allowing for the incorporation and protection against enzymatic degradation. Gelatin Microparticles are versatile particles and are easily loadable for the use within drug systems and alongside growth factors post-synthesis. Gelatin microparticles also allow for the biochemically controlled release of drug particles, growth factors, and other biological molecules.

The stem cell secretome is a collective term for the paracrine soluble factors produced by stem cells and utilized for their inter-cell communication. In addition to inter-cell communication, the paracrine factors are also responsible for tissue development, homeostasis and (re-)generation. The stem cell secretome consists of extracellular vesicles, specifically exosomes, microvesicles, membrane particles, peptides and small proteins (cytokines). The paracrine activity of stem cells, i.e. the stem cell secretome, has been found to be the predominant mechanism by which stem cell-based therapies mediate their effects in degenerative, auto-immune and/or inflammatory diseases. Though not only stem cells possess a secretome which influences their cellular environment, their secretome currently appears to be the most relevant for therapeutic use.

Artificial cartilage is a synthetic material made of hydrogels or polymers that aims to mimic the functional properties of natural cartilage in the human body. Tissue engineering principles are used in order to create a non-degradable and biocompatible material that can replace cartilage. While creating a useful synthetic cartilage material, certain challenges need to be overcome. First, cartilage is an avascular structure in the body and therefore does not repair itself. This creates issues in regeneration of the tissue. Synthetic cartilage also needs to be stably attached to its underlying surface, bone. Lastly, in the case of creating synthetic cartilage to be used in joint spaces, high mechanical strength under compression needs to be an intrinsic property of the material.

Entomoculture is the subfield of cellular agriculture which specifically deals with the production of insect tissue in vitro. It draws on principles more generally used in tissue engineering and has scientific similarities to Baculovirus Expression Vectors or soft robotics. The field has mainly been proposed because of its potential technical advantages over mammalian cells in generating cultivated meat. The name of the field was coined by Natalie Rubio at Tufts University.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 Petry F, Salzig D (2021). "Impact of Bioreactor Geometry on Mesenchymal Stem Cell Production in Stirred-Tank Bioreactors". Chemie Ingenieur Technik. 93 (10): 1537–1554. doi: 10.1002/cite.202100041 . ISSN   1522-2640. S2CID   238704820.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 Chen AK, Reuveny S, Oh SK (November 2013). "Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction". Biotechnology Advances. Stem Cell Engineering. 31 (7): 1032–1046. doi: 10.1016/j.biotechadv.2013.03.006 . PMID   23531528.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Li B, Wang X, Wang Y, Gou W, Yuan X, Peng J, et al. (April 2015). "Past, present, and future of microcarrier-based tissue engineering". Journal of Orthopaedic Translation. 3 (2): 51–57. doi:10.1016/j.jot.2015.02.003. PMC   5982391 . PMID   30035040.
  4. 1 2 3 4 5 6 7 8 9 10 11 12 13 Tsai AC, Pacak CA (July 2021). "Bioprocessing of Human Mesenchymal Stem Cells: From Planar Culture to Microcarrier-Based Bioreactors". Bioengineering. 8 (7): 96. doi: 10.3390/bioengineering8070096 . PMC   8301102 . PMID   34356203.
  5. 1 2 3 Badenes SM, Fernandes TG, Rodrigues CA, Diogo MM, Cabral JM (September 2016). "Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems". Journal of Biotechnology. 234: 71–82. doi:10.1016/j.jbiotec.2016.07.023. PMID   27480342.
  6. 1 2 3 Rafiq QA, Coopman K, Nienow AW, Hewitt CJ (March 2016). "Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors". Biotechnology Journal. 11 (4): 473–486. doi:10.1002/biot.201400862. PMC   4991290 . PMID   26632496.
  7. ↑ Chen P, Luo Z, Güven S, Tasoglu S, Ganesan AV, Weng A, Demirci U (September 2014). "Microscale assembly directed by liquid-based template". Advanced Materials. 26 (34): 5936–41. doi:10.1002/adma.201402079. PMC   4159433 . PMID   24956442.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.